Skip to main content

Find Clinical Trials

Home
Conditions
Hepatocellular Carcinoma

Clinical trial condition

Hepatocellular Carcinoma

Explore clinical trials studying Hepatocellular Carcinoma. Study availability and eligibility vary by location and protocol.

1,013 public trials 264 recruiting studies

Refine in advanced search Browse all conditions

Hepatocellular Carcinoma trial results

Recruiting

Study on the Classification of Comprehensive Treatment Effect of Hepatocellular Carcinoma

NCT06542796

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
Locations: 2ndAffiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH

NCT06813508

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations: IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy

View Trial Details

Recruiting

HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma

NCT06333561

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations: Chinese PLA General hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Multi-modal Characterisation of Hepatocellular Carcinoma (HCC) Treated With Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National Cohort

NCT06334965

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Service de Médecine Nucléaire, Hôpital Beaujon Clichy, France

Beaujon hospital Clichy, France

CHU Nantes Nantes, France

Service de Médecine Nucléaire, CHU de Nantes Nantes, France

View Trial Details

Recruiting

TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT

NCT06622031

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
Locations: Chinese PLA General hospital Beijing, None Selected, China

View Trial Details

Recruiting

Comparison of the Incidence of Delirium Caused by Different Anesthetic Agents in Patients Undergoing Liver Transplantation

NCT06767579

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
Locations: Department of Anesthesiology and Pain Medicine Yonsei University College of Medicine Seoul, South Korea

View Trial Details

Recruiting

The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage HepatoCellular Carcinoma

NCT04803994

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: LKH - Univ. Klinikum Graz Graz, Austria

Medzinische Universität Innsbruck Innsbruck, Austria

Klinikum Klagenfurt am Wörthersee Klagenfurt, Austria

Ordensklinikum Linz Linz, Austria

View all 72 locations

View Trial Details

Recruiting

TACE Using Idarubicin Versus Doxorubicin Chemoemulsion in Patients with Hepatocellular Carcinoma

NCT06114082

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Seoul National University Hospital Seoul, South Korea

View Trial Details

Recruiting

Radiation Major Hepatectomy to Selectively Treat Large Unifocal Hepatocellular Carcinoma

NCT06178198

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Seoul National University Hospital Seoul, South Korea

View Trial Details

Recruiting

Fruquintinib After ICIs Treatment in Unresectable Hepatocellular Carcinoma

NCT06446154

Conditions: Adenocarcinoma, Anti-angiogenic Therapy, Carcinoma, +12 more
Locations: Sun Yat-sen university cancer center Guangzhou, Guangdong, China

View Trial Details